Jäger R - Search Results

1

Allelic imbalance in CALR somatic mutagenesis.

Harutyunyan AS, Jäger R, Chen D, Berg T, Rumi E, Gisslinger B, Pietra D, Gisslinger H, Cazzola M, Kralovics R. Harutyunyan AS, et al. Among authors: jager r. Leukemia. 2015 Jun;29(6):1431-5. doi: 10.1038/leu.2015.3. Epub 2015 Jan 8. Leukemia. 2015. PMID: 25567134 Free PMC article. No abstract available.

2

Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F.

Schaub FX, Jäger R, Looser R, Hao-Shen H, Hermouet S, Girodon F, Tichelli A, Gisslinger H, Kralovics R, Skoda RC. Schaub FX, et al. Among authors: jager r. Blood. 2009 Feb 26;113(9):2022-7. doi: 10.1182/blood-2008-07-167056. Epub 2008 Dec 1. Blood. 2009. PMID: 19047681 Free article.

3

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms.

Olcaydu D, Harutyunyan A, Jäger R, Berg T, Gisslinger B, Pabinger I, Gisslinger H, Kralovics R. Olcaydu D, et al. Among authors: jager r. Nat Genet. 2009 Apr;41(4):450-4. doi: 10.1038/ng.341. Epub 2009 Mar 15. Nat Genet. 2009. PMID: 19287385

4

Molecular basis and clonal evolution of myeloproliferative neoplasms.

Jäger R, Kralovics R. Jäger R, et al. Haematologica. 2010 Apr;95(4):526-9. doi: 10.3324/haematol.2009.019570. Haematologica. 2010. PMID: 20378573 Free PMC article. No abstract available.

5

Deletions of the transcription factor Ikaros in myeloproliferative neoplasms.

Jäger R, Gisslinger H, Passamonti F, Rumi E, Berg T, Gisslinger B, Pietra D, Harutyunyan A, Klampfl T, Olcaydu D, Cazzola M, Kralovics R. Jäger R, et al. Leukemia. 2010 Jul;24(7):1290-8. doi: 10.1038/leu.2010.99. Epub 2010 May 27. Leukemia. 2010. PMID: 20508609

6

Molecular pathogenesis of Philadelphia chromosome negative chronic myeloproliferative neoplasms.

Jäger R, Kralovics R. Jäger R, et al. Curr Cancer Drug Targets. 2011 Jan;11(1):20-30. doi: 10.2174/156800911793743628. Curr Cancer Drug Targets. 2011. PMID: 21062246 Review.

7

The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms.

Olcaydu D, Rumi E, Harutyunyan A, Passamonti F, Pietra D, Pascutto C, Berg T, Jäger R, Hammond E, Cazzola M, Kralovics R. Olcaydu D, et al. Among authors: jager r. Haematologica. 2011 Mar;96(3):367-74. doi: 10.3324/haematol.2010.034488. Epub 2010 Dec 20. Haematologica. 2011. PMID: 21173100 Free PMC article.

8

Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression.

Klampfl T, Harutyunyan A, Berg T, Gisslinger B, Schalling M, Bagienski K, Olcaydu D, Passamonti F, Rumi E, Pietra D, Jäger R, Pieri L, Guglielmelli P, Iacobucci I, Martinelli G, Cazzola M, Vannucchi AM, Gisslinger H, Kralovics R. Klampfl T, et al. Among authors: jager r. Blood. 2011 Jul 7;118(1):167-76. doi: 10.1182/blood-2011-01-331678. Epub 2011 Apr 29. Blood. 2011. PMID: 21531982 Free article.

9

MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia.

Clarke M, Dumon S, Ward C, Jäger R, Freeman S, Dawood B, Sheriff L, Lorvellec M, Kralovics R, Frampton J, García P. Clarke M, et al. Among authors: jager r. Leukemia. 2013 Mar;27(3):661-70. doi: 10.1038/leu.2012.241. Epub 2012 Aug 22. Leukemia. 2013. PMID: 22910183 Free PMC article.

10

Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms.

Jäger R, Harutyunyan AS, Rumi E, Pietra D, Berg T, Olcaydu D, Houlston RS, Cazzola M, Kralovics R. Jäger R, et al. Am J Hematol. 2014 Dec;89(12):1107-10. doi: 10.1002/ajh.23842. Epub 2014 Sep 26. Am J Hematol. 2014. PMID: 25196853 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters